PATENT CLAIM ANALYSIS

Application Number: 16196726
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "401000"]

Abstract:
The present disclosure provides novel formulations for treating foot or hand pain by topically administering a sympathomimetic drug, particularly oxymetazoline, to the skin of the foot or hand.

Claim (Index 4):
The method of  claim 1 , wherein the one or more antidepressants or pharmaceutically acceptable salts thereof is selected from the group consisting of amitriptyline, clomipramine, desapramine, imipramine, doxepine, amoxapine, maprotiline, nortriptyline, protriptyline, trimipramine and buproprion.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 98.0
- Lexical Diversity: 1.19231
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14231096', '13262704', '14027033', '15490011', '15498991']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7686883948393564
- 35 USC 102 Novelty (BERT): 0.5659126772792016
- Combined Prediction Score: 0.7484108230833408
- Mean Citation Score: 239.13687400000003
- Max Citation Score: 512.20874
- Similarity Product: 322.3601919805741

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test